ESR1 and breast cancer: A recent study found that 4-methylumbelliferone can significantly reduce the migration, adhesion, and invasion of estrogen receptor cells in BC and reduce the expressions and activities of several pro-tumor matrix-degrading enzymes and pro-inflammatory molecules.